Foundation Venture Capital Group invests in spinal cord injuries specialist
Foundation Venture Capital Group has made an investment in Celvive, a start-up company working to develop technology that would treat patients with chronic spinal cord injuries with their own adult stem cells. FVCG has made an initial investment of USD175,000 in Celvive, which can go up to USD500,000 pending completion


